rs148464316
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_000379.4(XDH):c.1885G>T(p.Val629Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000541 in 1,614,178 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000379.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
XDH | NM_000379.4 | c.1885G>T | p.Val629Phe | missense_variant | 18/36 | ENST00000379416.4 | NP_000370.2 | |
XDH | XM_011533095.3 | c.1882G>T | p.Val628Phe | missense_variant | 18/36 | XP_011531397.1 | ||
XDH | XM_011533096.3 | c.1885G>T | p.Val629Phe | missense_variant | 18/29 | XP_011531398.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
XDH | ENST00000379416.4 | c.1885G>T | p.Val629Phe | missense_variant | 18/36 | 1 | NM_000379.4 | ENSP00000368727.3 |
Frequencies
GnomAD3 genomes AF: 0.000414 AC: 63AN: 152182Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.000270 AC: 68AN: 251390Hom.: 0 AF XY: 0.000213 AC XY: 29AN XY: 135882
GnomAD4 exome AF: 0.000555 AC: 811AN: 1461878Hom.: 2 Cov.: 32 AF XY: 0.000509 AC XY: 370AN XY: 727240
GnomAD4 genome AF: 0.000414 AC: 63AN: 152300Hom.: 1 Cov.: 33 AF XY: 0.000336 AC XY: 25AN XY: 74482
ClinVar
Submissions by phenotype
Hereditary xanthinuria type 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. - |
Xanthinuria type II Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 03, 2022 | This sequence change replaces valine, which is neutral and non-polar, with phenylalanine, which is neutral and non-polar, at codon 629 of the XDH protein (p.Val629Phe). This variant is present in population databases (rs148464316, gnomAD 0.05%). This variant has not been reported in the literature in individuals affected with XDH-related conditions. ClinVar contains an entry for this variant (Variation ID: 571131). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at